Alyssa Cull

830 total citations
15 papers, 324 citations indexed

About

Alyssa Cull is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Alyssa Cull has authored 15 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Hematology and 6 papers in Immunology. Recurrent topics in Alyssa Cull's work include Acute Myeloid Leukemia Research (6 papers), Epigenetics and DNA Methylation (5 papers) and Immune cells in cancer (5 papers). Alyssa Cull is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Epigenetics and DNA Methylation (5 papers) and Immune cells in cancer (5 papers). Alyssa Cull collaborates with scholars based in Canada, United Kingdom and United States. Alyssa Cull's co-authors include Michael J. Rauh, Brooke Snetsinger, Rena Buckstein, Richard A. Wells, David G. Kent, Erica B. Esrick, Peter J. Campbell, Myriam Armant, Emily Mitchell and David A. Williams and has published in prestigious journals such as Nature Medicine, Blood and Frontiers in Immunology.

In The Last Decade

Alyssa Cull

14 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alyssa Cull Canada 6 160 151 107 77 44 15 324
Antonella Santoro United Kingdom 6 195 1.2× 116 0.8× 71 0.7× 38 0.5× 38 0.9× 10 290
Hussein Ghamlouch France 11 154 1.0× 79 0.5× 136 1.3× 112 1.5× 34 0.8× 27 341
Kathryn Potts United States 10 149 0.9× 148 1.0× 117 1.1× 27 0.4× 27 0.6× 15 343
Ciarán J. Mooney Ireland 8 96 0.6× 110 0.7× 66 0.6× 31 0.4× 26 0.6× 8 262
Jodie Ulaszek United States 6 154 1.0× 106 0.7× 66 0.6× 47 0.6× 25 0.6× 9 329
Jingliao Zhang China 10 140 0.9× 96 0.6× 50 0.5× 43 0.6× 26 0.6× 32 268
Georgi Manukjan Germany 11 88 0.6× 137 0.9× 39 0.4× 37 0.5× 20 0.5× 26 265
Kyle Ferchen United States 5 148 0.9× 79 0.5× 103 1.0× 20 0.3× 38 0.9× 9 237
Joseph Stegner United States 6 116 0.7× 98 0.6× 101 0.9× 52 0.7× 14 0.3× 6 312
Richard XuFeng United States 6 214 1.3× 127 0.8× 73 0.7× 46 0.6× 35 0.8× 8 349

Countries citing papers authored by Alyssa Cull

Since Specialization
Citations

This map shows the geographic impact of Alyssa Cull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alyssa Cull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alyssa Cull more than expected).

Fields of papers citing papers by Alyssa Cull

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alyssa Cull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alyssa Cull. The network helps show where Alyssa Cull may publish in the future.

Co-authorship network of co-authors of Alyssa Cull

This figure shows the co-authorship network connecting the top 25 collaborators of Alyssa Cull. A scholar is included among the top collaborators of Alyssa Cull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alyssa Cull. Alyssa Cull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cull, Alyssa & David L. Joly. (2025). Development and validation of a minimal SNP genotyping panel for the differentiation of Cannabis sativa cultivars. BMC Genomics. 26(1). 83–83. 2 indexed citations
2.
Cull, Alyssa, David G. Kent, & Alan J. Warren. (2024). Emerging genetic technologies informing personalized medicine in Shwachman-Diamond syndrome and other inherited BMF disorders. Blood. 144(9). 931–939. 1 indexed citations
3.
Belmonte, Miriam, Nina Friesgaard Øbro, Juan Li, et al.. (2024). Increased CXCL10 (IP-10) is associated with advanced myeloproliferative neoplasms and its loss dampens erythrocytosis in mouse models. Experimental Hematology. 135. 104246–104246. 1 indexed citations
4.
Chapman, Michael Spencer, Alyssa Cull, Marioara F. Ciuculescu, et al.. (2023). Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease. Nature Medicine. 29(12). 3175–3183. 27 indexed citations
5.
Cull, Alyssa, et al.. (2021). Exploiting Single-Cell Tools in Gene and Cell Therapy. Frontiers in Immunology. 12. 702636–702636. 28 indexed citations
6.
Cull, Alyssa, Michael Spencer Chapman, Marioara F. Ciuculescu, et al.. (2021). Clonal Tracking By Whole Genome Sequencing Permits Comprehensive Mapping of the Genomic Landscape in Pre- and Post-Gene Therapy Sickle Cell Patients. Blood. 138(Supplement 1). 559–559. 4 indexed citations
7.
Kuciński, Iwo, Alyssa Cull, Melania Barile, et al.. (2021). 3008 – A HIGHLY EFFICIENT REPORTER SYSTEM FOR IDENTIFYING AND CHARACTERIZING IN VITRO EXPANDED HEMATOPOIETIC STEM CELLS. Experimental Hematology. 100. S47–S47. 2 indexed citations
8.
Cull, Alyssa, Brooke Snetsinger, Rena Buckstein, Richard A. Wells, & Michael J. Rauh. (2017). Tet2 restrains inflammatory gene expression in macrophages. Experimental Hematology. 55. 56–70.e13. 222 indexed citations
9.
Cull, Alyssa, Brooke Snetsinger, David Good, et al.. (2017). Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia. Leukemia Research. 65. 5–13. 15 indexed citations
10.
Cull, Alyssa & Michael J. Rauh. (2017). Success in bone marrow failure? Novel therapeutic directions based on the immune environment of myelodysplastic syndromes. Journal of Leukocyte Biology. 102(2). 209–219. 13 indexed citations
11.
Cull, Alyssa, Brooke Snetsinger, & Michael J. Rauh. (2016). Tet2 Deficiency Leads to an Increased Inflammatory Phenotype in Murine Macrophages. Blood. 128(22). 708–708. 2 indexed citations
12.
Cull, Alyssa, Brooke Snetsinger, David Good, et al.. (2016). Microenvironmental Links Between TET2/DNMT3A Mutations and Arginase 1 Overexpression in Human MDS/CMML. Blood. 128(22). 3164–3164.
13.
Cull, Alyssa, Brooke Snetsinger, & Michael J. Rauh. (2015). Tet2 Is a Novel Regulator of Murine Macrophage Differentiation and Polarization. Blood. 126(23). 646–646. 5 indexed citations
14.
15.
Cull, Alyssa. (1992). Behavioural factors influencing the development and expression of chemotherapy induced side effects: a discussion of a paper by Dr Gary Morrow. Europe PMC (PubMed Central). 19. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonella Santoro Breakdown of academic impact, for papers by Hussein Ghamlouch Breakdown of academic impact, for papers by Kathryn Potts Breakdown of academic impact, for papers by Ciarán J. Mooney Breakdown of academic impact, for papers by Jodie Ulaszek Breakdown of academic impact, for papers by Jingliao Zhang Breakdown of academic impact, for papers by Georgi Manukjan Breakdown of academic impact, for papers by Kyle Ferchen Breakdown of academic impact, for papers by Joseph Stegner Breakdown of academic impact, for papers by Richard XuFeng
Rankless by CCL
2026